These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


263 related items for PubMed ID: 10901398

  • 1. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
    [Abstract] [Full Text] [Related]

  • 2. Effects of nitric oxide synthase inhibition and low-salt diet on blood pressure and mesenteric resistance artery remodelling in genetically hypertensive rats.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2001 Sep; 28(9):761-3. PubMed ID: 11560124
    [Abstract] [Full Text] [Related]

  • 3. Effect of simvastatin given alone and in combination with valsartan or enalapril on blood pressure and the structure of mesenteric resistance arteries and the basilar artery in the genetically hypertensive rat model.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2005 Sep; 32(1-2):76-85. PubMed ID: 15730439
    [Abstract] [Full Text] [Related]

  • 4. Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):919-25. PubMed ID: 16405447
    [Abstract] [Full Text] [Related]

  • 5. Prevention of increases in blood pressure and left ventricular mass and remodeling of resistance arteries in young New Zealand genetically hypertensive rats: the effects of chronic treatment with valsartan, enalapril and felodipine.
    Ledingham JM, Phelan EL, Cross MA, Laverty R.
    J Vasc Res; 2000 Nov; 37(2):134-45. PubMed ID: 10754398
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide synthase inhibition with N omega-nitro-L-arginine methyl ester affects blood pressure and cardiovascular structure in the genetically hypertensive rat strain.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):433-5. PubMed ID: 9171951
    [Abstract] [Full Text] [Related]

  • 7. Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonist.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 1996 Jun; 23(6-7):576-8. PubMed ID: 8800589
    [Abstract] [Full Text] [Related]

  • 8. Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats.
    de Gasparo M, Hess P, Clozel M, Persohn E, Roman D, Germann PG, Clozel JP, Webb RL.
    J Cardiovasc Pharmacol; 2002 Nov; 40(5):789-800. PubMed ID: 12409988
    [Abstract] [Full Text] [Related]

  • 9. Fluvastatin remodels resistance arteries in genetically hypertensive rats, even in the absence of any effect on blood pressure.
    Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):931-4. PubMed ID: 12207574
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats.
    Orange SJ, Ledingham JM, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):488-93. PubMed ID: 10874504
    [Abstract] [Full Text] [Related]

  • 11. Effects of chronic inhibition of nitric oxide synthase in the genetically hypertensive rat.
    Tucker EJ, Ledingham JM, Zheng Y, Laverty R.
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):647-9. PubMed ID: 10901399
    [Abstract] [Full Text] [Related]

  • 12. Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodelling.
    Ledingham JM, Laverty R.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1945-52. PubMed ID: 9886881
    [Abstract] [Full Text] [Related]

  • 13. Cellular changes induced by chronic nitric oxide inhibition in intact rat basilar arteries revealed by confocal microscopy.
    Arribas SM, González C, Graham D, Dominiczak AF, McGrath JC.
    J Hypertens; 1997 Dec; 15(12 Pt 2):1685-93. PubMed ID: 9488223
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.
    Tschudi MR, Criscione L, Novosel D, Pfeiffer K, Lüscher TF.
    Circulation; 1994 May; 89(5):2212-8. PubMed ID: 8181147
    [Abstract] [Full Text] [Related]

  • 15. Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction.
    de Gasparo M, Hess P, Nuesslein-Hildesheim B, Bruneval P, Clozel JP.
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):151-8. PubMed ID: 11967807
    [Abstract] [Full Text] [Related]

  • 16. Effect of chronic nitric oxide deficiency on angiotensin II-induced hypertrophy of rat basilar artery.
    Moreau P, Takase H, d'Uscio LV, Lüscher TF.
    Stroke; 1998 May; 29(5):1031-5; discussion 1035-6. PubMed ID: 9596254
    [Abstract] [Full Text] [Related]

  • 17. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats.
    Pereira LM, Bezerra DG, Machado DL, Mandarim-de-Lacerda CA.
    Clin Sci (Lond); 2004 Mar; 106(3):337-43. PubMed ID: 14629192
    [Abstract] [Full Text] [Related]

  • 18. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition.
    Moreau P, Takase H, Küng CF, van Rooijen MM, Schaffner T, Lüscher TF.
    Stroke; 1995 Oct; 26(10):1922-8; discussion 1928-9. PubMed ID: 7570749
    [Abstract] [Full Text] [Related]

  • 19. Structural changes in cerebral arteries following nitric oxide deprivation: a comparison between normotensive and hypertensive rats.
    Hsieh NK, Wang JY, Liu JC, Lee WH, Chen HI.
    Thromb Haemost; 2004 Jul; 92(1):162-70. PubMed ID: 15213857
    [Abstract] [Full Text] [Related]

  • 20. Remodelling of mesenteric arteries in genetically hypertensive rats cross-fostered from birth to normotensive Wistar rats.
    Ledingham JM, Ashton N.
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):859-64. PubMed ID: 16173948
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.